Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com
Update: 2025-10-31
Description
Corbus Pharmaceuticals' stock plummets 22% after announcing a $75M public stock offering, diluting existing investors' stakes. The company aims to fund drug pipeline development and general expenses, with Jefferies, RBC Capital Markets, LifeSci Capital, and Mizuho Securities as lead managers. The market's concern over risks outweighing rewards leads to a sharp sell-off.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




